南微医学
(688029)
| 流通市值：157.04亿 | | | 总市值：157.04亿 |
| 流通股本：1.88亿 | | | 总股本：1.88亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,087,348,453.36 | 2,016,173,516.57 | 1,861,391,563.06 | 1,886,624,959.06 |
| 交易性金融资产 | 118,643,953.77 | 1,505,634.43 | - | - |
| 应收票据及应收账款 | 541,679,464.42 | 555,073,852.64 | 546,632,984.63 | 434,093,889.07 |
| 其中：应收票据 | 194,724.65 | 184,938.34 | 23,194,725.52 | 57,934.8 |
| 应收账款 | 541,484,739.77 | 554,888,914.3 | 523,438,259.11 | 434,035,954.27 |
| 预付款项 | 28,682,390.11 | 28,437,254.82 | 44,709,306.2 | 32,009,120.01 |
| 其他应收款合计 | 11,877,412.99 | 21,868,593.28 | 12,769,444.14 | 13,554,875.58 |
| 存货 | 626,036,125.01 | 628,487,443.36 | 615,988,795.17 | 536,582,311.14 |
| 其他流动资产 | 61,715,789.41 | 83,885,227.16 | 141,948,334.21 | 417,913,863.84 |
| 流动资产合计 | 3,475,983,589.07 | 3,335,431,522.26 | 3,223,440,427.41 | 3,320,779,018.7 |
| 非流动资产: | | | | |
| 长期股权投资 | 52,514,223.16 | 49,363,872.96 | 63,442,686.57 | 59,795,713.32 |
| 其他权益工具投资 | 5,775,721.54 | 5,812,290.09 | 5,821,365.63 | 5,843,807.68 |
| 其他非流动金融资产 | 29,907,009.78 | 29,883,074.88 | 29,478,063 | 29,542,697.21 |
| 固定资产 | 914,416,466.9 | 926,083,918.24 | 928,114,385.28 | 926,465,628.26 |
| 在建工程 | 51,878,203.5 | 37,537,787.15 | 14,596,816.2 | 21,174,370.34 |
| 使用权资产 | 52,589,973.07 | 47,402,032.53 | 43,081,235.45 | 37,552,048.42 |
| 无形资产 | 74,548,890.72 | 81,454,995.78 | 71,658,431.53 | 74,816,455.63 |
| 商誉 | 410,091,863.64 | 410,406,433.21 | 405,889,569.89 | 169,599,585.22 |
| 长期待摊费用 | 42,968,136.24 | 42,723,106.64 | 44,374,765.46 | 44,976,574.13 |
| 递延所得税资产 | 36,823,813.39 | 36,734,248.82 | 38,507,097.43 | 33,451,790.09 |
| 其他非流动资产 | 44,914,317.29 | 74,629,633.63 | 62,830,644.74 | 55,609,260.81 |
| 非流动资产合计 | 1,716,428,619.23 | 1,742,031,393.93 | 1,707,795,061.18 | 1,458,827,931.11 |
| 资产总计 | 5,192,412,208.3 | 5,077,462,916.19 | 4,931,235,488.59 | 4,779,606,949.81 |
| 流动负债: | | | | |
| 短期借款 | 190,850,674.64 | 66,839,768.92 | 11,211,046.31 | - |
| 应付票据及应付账款 | 373,956,233.29 | 404,200,989.98 | 439,646,636.66 | 510,109,777.07 |
| 其中：应付票据 | 8,616,280.08 | 29,420,047.16 | 29,433,478.82 | 49,891,077.5 |
| 应付账款 | 365,339,953.21 | 374,780,942.82 | 410,213,157.84 | 460,218,699.57 |
| 预收款项 | 293,626.82 | 1,116,739.52 | 1,599,722.3 | 1,116,809.7 |
| 合同负债 | 51,610,223 | 64,598,811.37 | 45,756,933.92 | 30,682,345.64 |
| 应付职工薪酬 | 108,621,335.33 | 96,271,200.56 | 72,217,987.56 | 144,064,326.06 |
| 应交税费 | 75,242,269.75 | 91,849,591.2 | 71,677,182.48 | 48,868,849.74 |
| 其他应付款合计 | 39,385,564.29 | 51,382,587.59 | 48,477,170.97 | 54,288,406.26 |
| 一年内到期的非流动负债 | 17,863,180.09 | 14,096,715.3 | 12,554,088.46 | 14,253,281.59 |
| 其他流动负债 | 5,966,123.05 | 7,243,382.3 | 3,927,172.51 | 3,104,701.65 |
| 流动负债合计 | 863,789,230.26 | 797,599,786.74 | 707,067,941.17 | 806,488,497.71 |
| 非流动负债: | | | | |
| 租赁负债 | 37,612,175.9 | 35,081,102.54 | 32,579,493.67 | 24,778,083.88 |
| 长期应付款 | 37,149,810.98 | 37,649,810.98 | 38,159,810.98 | 37,649,810.98 |
| 递延收益 | 8,300,730.93 | 8,368,532.96 | 8,406,620.39 | 9,495,128.01 |
| 递延所得税负债 | 1,786,784.27 | 1,962,745.24 | 1,826,315.38 | 1,831,975.55 |
| 非流动负债合计 | 84,849,502.08 | 83,062,191.72 | 80,972,240.42 | 73,754,998.42 |
| 负债合计 | 948,638,732.34 | 880,661,978.46 | 788,040,181.59 | 880,243,496.13 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 187,847,422 | 187,847,422 | 187,847,422 | 187,847,422 |
| 资本公积 | 1,919,132,274.49 | 1,918,289,841.16 | 1,917,456,252.27 | 1,916,627,085.6 |
| 减:库存股 | 69,618,398.48 | 60,990,801.09 | 60,013,409.36 | 60,013,409.36 |
| 其他综合收益 | 31,781,877.8 | 34,174,530.64 | 14,344,807.89 | 7,740,813.41 |
| 盈余公积 | 109,690,385.48 | 109,690,385.48 | 109,690,385.48 | 109,690,385.48 |
| 未分配利润 | 1,893,123,302.34 | 1,840,654,401.18 | 1,825,137,303.8 | 1,664,200,364.1 |
| 归属于母公司股东权益合计 | 4,071,956,863.63 | 4,029,665,779.37 | 3,994,462,762.08 | 3,826,092,661.23 |
| 少数股东权益 | 171,816,612.33 | 167,135,158.36 | 148,732,544.92 | 73,270,792.45 |
| 股东权益合计 | 4,243,773,475.96 | 4,196,800,937.73 | 4,143,195,307 | 3,899,363,453.68 |
| 负债和股东权益合计 | 5,192,412,208.3 | 5,077,462,916.19 | 4,931,235,488.59 | 4,779,606,949.81 |
| 公告日期 | 2025-10-28 | 2025-08-12 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |